Recent News: Diagnosis

Print
and/or
9 News Items found

Finding

Research Uncovers the Genetic Causes of Aggressive Leukemia in Children

Researchers have found that the genetic changes that cause pediatric leukemia are different from those that lead to leukemia in adults.

Alex Kentsis in his lab

In The Clinic

Analyzing Spinal Fluid Could Guide Brain Tumor Diagnosis and Treatment

Cancer DNA taken from spinal fluid could serve as a liquid biopsy that provides information on brain tumor mutations.

MRI of brain and spinal fluid in green

In the Lab

Researchers Identify Why Women May Develop Resistance to a New Class of Breast Cancer Drugs

Clues emerge about why promising new breast cancer drugs sometimes don’t work — and what might be done about it.

Image of dividing breast cancer cells taken with electron microscope.

In the Clinic

Liquid Biopsy Is Effective at Guiding Treatment of Lung Cancer, Study Finds

The initial results of an ongoing study show that a liquid biopsy has advantages over a tissue biopsy for people with lung cancer.

A tube of blood superimposed on a lung and a DNA helix

In the News

#ASCO17: Post-Conference Roundup of Themes and Trends

Read up on the progress being made in several key areas of cancer research, including immunotherapy, targeted therapy, precision surgery, and epigenetics.

American Society of Clinical Oncology logo

Announcement

Expanding the Impact of Precision Medicine to Fuel Discoveries

MSK’s Functional Genomics Initiative will enable basic scientists to take full advantage of the massive amount of data produced by tumor sequencing.

Christina Leslie and John Petrini

In the Lab

Researchers Identify Mutations that Cause Some Breast Cancers to Resist Treatment

Memorial Sloan Kettering researchers have found genetic mutations that cause some breast cancers to develop resistance to hormone therapy.

Pictured: Sarat Chandarlapaty

In the Lab

Faster than the Speed of Light: New Imaging Approach Could Measure Tumor Activity

A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.

Pictured: Daniel Thorek & Jan Grimm